Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
BMC Medical Research Methodology
|
April 12, 2008
Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database
Martin Daumer, Ulrike Held, Katja Ickstadt, et al.
Journal of the Neurological Sciences
|
August 20, 2016
Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes
Jan-Patrick Stellmann, Midia Jlussi, Anneke Neuhaus, et al.
Digital Biomarkers
|
February 26, 2020
Continuous Monitoring of Patient Mobility for 18 Months Using Inertial Sensors following Traumatic Knee Injury: A Case Study
Arne Mueller, Holger Hoefling, Timur Nuritdinow, et al.
JAMA Neurology
|
February 15, 2013
Early relapses, onset of progression, and late outcome in multiple sclerosis
Antonio Scalfari, Anneke Neuhaus, Martin Daumer, et al.
Plos One
|
August 20, 2011
Association between walking speed and age in healthy, free-living individuals using mobile accelerometry--a cross-sectional study
Michaela Schimpl, Carmel Moore, Christian Lederer, et al.
Frontiers in Pediatrics
|
February 15, 2021
Accelerometric Gait Analysis Devices in Children-Will They Accept Them? Results From the AVAPed Study
Isabella Wiedmann, Marcello Grassi, Ibrahim Duran, et al.
Brain : a Journal of Neurology
|
June 11, 2010
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability
Antonio Scalfari, Anneke Neuhaus, Alexandra Degenhardt, et al.
Plos One
|
May 14, 2020
Correction: Long-term gait measurements in daily life: Results from the Berlin Aging Study II (BASE-II)
Jörn Kiselev, Timur Nuritdinow, Dominik Spira, et al.
Plos One
|
December 12, 2019
Long-term gait measurements in daily life: Results from the Berlin Aging Study II (BASE-II)
Jörn Kiselev, Timur Nuritdinow, Dominik Spira, et al.
Plos One
|
December 5, 2012
Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data
Jan-Patrick Stellmann, Anneke Neuhaus, Lena Herich, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
BMC Medical Research Methodology
|
April 12, 2008
Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database
Martin Daumer, Ulrike Held, Katja Ickstadt, et al.
Journal of the Neurological Sciences
|
August 20, 2016
Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes
Jan-Patrick Stellmann, Midia Jlussi, Anneke Neuhaus, et al.
Digital Biomarkers
|
February 26, 2020
Continuous Monitoring of Patient Mobility for 18 Months Using Inertial Sensors following Traumatic Knee Injury: A Case Study
Arne Mueller, Holger Hoefling, Timur Nuritdinow, et al.
JAMA Neurology
|
February 15, 2013
Early relapses, onset of progression, and late outcome in multiple sclerosis
Antonio Scalfari, Anneke Neuhaus, Martin Daumer, et al.
Plos One
|
August 20, 2011
Association between walking speed and age in healthy, free-living individuals using mobile accelerometry--a cross-sectional study
Michaela Schimpl, Carmel Moore, Christian Lederer, et al.
Frontiers in Pediatrics
|
February 15, 2021
Accelerometric Gait Analysis Devices in Children-Will They Accept Them? Results From the AVAPed Study
Isabella Wiedmann, Marcello Grassi, Ibrahim Duran, et al.
Brain : a Journal of Neurology
|
June 11, 2010
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability
Antonio Scalfari, Anneke Neuhaus, Alexandra Degenhardt, et al.
Plos One
|
May 14, 2020
Correction: Long-term gait measurements in daily life: Results from the Berlin Aging Study II (BASE-II)
Jörn Kiselev, Timur Nuritdinow, Dominik Spira, et al.
Plos One
|
December 12, 2019
Long-term gait measurements in daily life: Results from the Berlin Aging Study II (BASE-II)
Jörn Kiselev, Timur Nuritdinow, Dominik Spira, et al.
Plos One
|
December 5, 2012
Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data
Jan-Patrick Stellmann, Anneke Neuhaus, Lena Herich, et al.
Page
of 5